Latest filing published 22 May 2024 for Aurinia Pharmaceuticals Inc..
Filing timeline
BuySaleInsider track record
R. Hector MacKay-Dunn: trading record in brief
R. Hector MacKay-Dunn appears in our data through filings on Aurinia Pharmaceuticals Inc. shares, published by SEC (Form 4). Between 26 June 2019 and 21 May 2024, the trades on record add up to 6 filings.
Purchases make up the whole of the open-market record (1 purchase, €6,490). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 2 option exercises.
The latest filing, published on 22 May 2024, reports an option exercise in Aurinia Pharmaceuticals Inc. The most recent open-market purchase was published on 22 January 2020, 2,484 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to R. Hector MacKay-Dunn
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 9,310 sharesCommon SharesTSXSEDI:4317769
- 5,630 shares@ CA$5.7413.2% of flowCommon SharesTSXSEDI:4317772
- Common SharesTSXSEDI:4132480
- 8,733 shares@ CA$14.5060.6% of flowCommon SharesTSXSEDI:4132483
- 4,818 shares@ CA$15.2034.9% of flowCommon SharesTSXSEDI:4132510
- 500 shares@ CA$18.8169100.0% of flowCommon SharesTSXSEDI:3487142Canonical exit: 21 Apr 2020 (T+90)
6 of 6 declarations
